It’s becoming more common to treat Crohn’s disease with 2 biologic medications, or a biologic and a small molecule drug. Find ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence ...

A drug that’s derived from living things and often administered by self-injection? Yeah, you’ve (understandably) got questions about biologic drugs—and we’ve got a handful you can go ahead and add to ...

Psoriasis treatment has come a long way in the last 30 years. There’s no cure, but medication can help you gain control of your symptoms. If your current treatment doesn’t help enough, the doctor ...

Here are six factors to consider and discuss with your doctor before transitioning to a biologic for moderate to severe Crohn's disease.

A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

Please provide your email address to receive an email when new articles are posted on . In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a ...

CORRECTED April 15, 2024 // An earlier version of this article stated incorrect percentages of patients who never received any biologics during the study's 3-year period but improved rapidly or ...

After 1 year, overall treatment switch rates were 14.4%, while after 2 years, switch rates were 26%. Switching therapies was common in patients with psoriasis who used biologics over the course of 24 ...

Even with biologics changing the treatment paradigm for ulcerative colitis more than 2 decades ago, patients have a similar ...